Evidence map›Paper›PMID 39628036›Full record

ArticleEpilepsia open2025

The appearance of scalp high-frequency oscillations is associated with poor seizure control in pediatric epilepsy patients.

Keisuke Maeda, Nami Hosoda, Himari Tsuboi, Honoka Naito, Chiaki Kudo, Junichi Fukumoto, Shiho Fujita, Naohiro Ichino, Keisuke Osakabe, Keiko Sugimoto and 2 more

Abstract read
In one paragraph

Article in Epilepsia open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Keisuke MaedaDepartment of Clinical Physiology, Fujita Health University School of Medical Sciences, Toyoake, Japan.ORCID 0000-0001-8916-2687
Nami HosodaDepartment of Clinical Laboratory, Fujita Health University Hospital, Toyoake, Japan.
Himari TsuboiDepartment of Clinical Laboratory, Fujita Health University Hospital, Toyoake, Japan.
Honoka NaitoDepartment of Clinical Laboratory, Fujita Health University Hospital, Toyoake, Japan.
Chiaki KudoDepartment of Clinical Laboratory, Fujita Health University Hospital, Toyoake, Japan.
Junichi FukumotoDepartment of Clinical Laboratory, Fujita Health University Hospital, Toyoake, Japan.
Shiho FujitaDepartment of Clinical Laboratory, Fujita Health University Hospital, Toyoake, Japan.
Naohiro IchinoDepartment of Clinical Physiology, Fujita Health University School of Medical Sciences, Toyoake, Japan.
Keisuke OsakabeDepartment of Clinical Physiology, Fujita Health University School of Medical Sciences, Toyoake, Japan.
Keiko SugimotoDepartment of Medical Sciences Education, Fujita Health University School of Medical Sciences, Toyoake, Japan.
Shunta YamaguchiDepartment of Clinical Physiology, Fujita Health University School of Medical Sciences, Toyoake, Japan.
Naoko IshiharaDepartment of Pediatrics, Fujita Health University School of Medicine, Toyoake, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveEpilepsy treatment with anti-seizure medications (ASMs) is based on careful assessment of the balance between the likelihood of further seizures and the risk of side effects of treatment. However, there is currently no established biomarker to ascertain seizure control status with ASMs. High-frequency oscillations (HFOs), transient bursts of EEG activity with frequencies beyond 80 Hz, are a new and promising noninvasive epilepsy biomarker. We compared the risk of scalp HFO appearance between pediatric patients with good and poor seizure control by treatment with ASMs.

methodsA total of 72 epilepsy patients (aged 0-18 years, 39 males) with good and poor seizure control with ASMs participated in this study. We applied a validated automated detector to determine HFO and spike. We calculated the odds ratios (ORs) for scalp HFO and spike appearance according to seizure control status by multiple logistic regression analysis.

resultsScalp HFO was seen more commonly and with a significantly higher detection rate in patients with poor seizure control as compared with patients with good seizure control for both ripple and fast ripple. These significant associations were found for both focal and generalized epilepsy. The ORs for scalp HFO appearance adjusted for confounding factors were significantly higher in patients with poor seizure control compared to those with good seizure control (ripple: OR [95% CI] = 11.91 [2.21-64.30], p = 0.004; fast ripple: 4.98 [1.03-24.09], p = 0.046). There were no significant associations between spike appearance and seizure control status. SIGNIFICANCE: We found an increased risk of scalp HFO appearance in patients with poor seizure control. The results of this study support that scalp HFO is associated with patients having frequent seizures after treatment in both ripple and fast ripple. PLAIN LANGUAGE SUMMARY: This study analyzed scalp high-frequency oscillations and spikes in pediatric patients with various types of epilepsy who were being treated using ASMs. The results showed that an increased risk of scalp HFO appearance was observed in patients with poor seizure control compared to those with good seizure control. These findings were observed in both the ripple (80-250 Hz) and fast ripple (250-500 Hz) bands. The scalp HFO is associated with patients having frequent seizures after treatment in both ripple and fast ripple.

Indexed as

AnticonvulsantsEpilepsyScalpSeizuresAdolescentChildChild, PreschoolElectroencephalographyFemaleHumansInfantInfant, NewbornMaleAnticonvulsantsanti‐seizure medicationfast ripplehigh‐frequency oscillationpediatric epilepsyripplespike

Identifiers

PMID39628036
PMCPMC11803266

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.